Neoadjuvant chemotherapy for primary breast cancer: lessons learned and opportunities to optimize therapy.

Annals of surgical oncology : the official journal of the Society of Surgical Oncology

Volumn 11, Issue 1 Suppl, 2004, Pages

  Esserman, Laura ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMOTHERAPY; BREAST TUMOR; GENETICS; HUMAN; PROGNOSIS; REMISSION; REVIEW; SEGMENTAL MASTECTOMY;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; HUMANS; MASTECTOMY, SEGMENTAL; PROGNOSIS; REMISSION INDUCTION;

MLCS; MLOWN;

EID: 2142811031     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf02524789     Document Type: Review

References (60)